Scenarios that move GMAB

Genmab A/S - American Depositary Shares

Scenarios that move GMAB: 2 analyses, 1 positive, 1 negative.

1. 2026-10-05 · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▲ · impact +88 · confidence high · horizon immediate
2. 2026-09-21 · CHMP backs CORT's Lifyorli combo for ovarian cancer — ▼ · impact -30 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing